The objective of this open, multicentre, randomized con- were given in the upper outer quadrant of the gluteus maximus P ⍧ 0.08). Post-injection fever was reported in 1.4% with muscle, using a standard gauge injection needle.
Introduction
cycle. The effects of the study medication on occurrence and onset Intramuscular (i.m.) injections of human menopausal gonadoof injection site pain (0-1 h, 1-3 h and 3-24 h), injection site redness trophin (HMG) preparations sometimes cause pain, swelling and post-injection fever were assessed by the subjects after each and redness at the injection site (Li and Hindle, 1993; Dore injection by means of completing the questionnaires. In addition to the assessments performed to study the treatment effect of the study et al., 1994) . Until recently, there have been no reasons In total, 250 subjects were randomized (125 to Humegon and 125 to Pergonal), of whom 181 were included in analyses (89 with Humegon and 92 with Pergonal). A total of 69 enrolled (Table I) . The 181 evaluable patients recorded a total of 1547 injections with the study drugs. The mean number of injections in both with Pergonal (not significant). Post-injection fever was reported in 1.4% of injections with Humegon and in 1.1% groups was 8.8 Ϯ 2.5 with Humegon and 8.3 Ϯ 2.5 with Pergonal. The distribution of the number of injections per with Pergonal (P ϭ 0.80) (Table II) . Also, when percentages were based on the number of patients, there were no statistically patient over the study preparations did not indicate relevant between-group differences (Figure 1 ). significant differences between Humegon and Pergonal with respect to injection site pain (83.1 versus 81.5%; P ϭ 0.93), Injection site pain was reported in 48.9% of injections with Humegon and in 44.9% with Pergonal, which was not injection site redness (29.2 versus 43.5%; P ϭ 0.07) or postinjection fever (4.6 versus 5.5%; P ϭ 0.94). statistically different between groups (P ϭ 0.45). Redness was reported in 15.5% of injections with Humegon and in 24.0%
Of the 48.
9% of injections with Humegon in which injection
Injection site pain with intramuscular gonadotrophins site pain was reported, onset started usually within 1 h. In the
